6mt2: Difference between revisions
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Crystal structure of Inorganic Pyrophosphatase from Medicago truncatula (I23 crystal form)== | |||
<StructureSection load='6mt2' size='340' side='right'caption='[[6mt2]], [[Resolution|resolution]] 2.89Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[6mt2]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Medicago_truncatula Medicago truncatula]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6MT2 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6MT2 FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.89Å</td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6mt2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6mt2 OCA], [https://pdbe.org/6mt2 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6mt2 RCSB], [https://www.ebi.ac.uk/pdbsum/6mt2 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6mt2 ProSAT]</span></td></tr> | |||
</table> | |||
== Function == | |||
[https://www.uniprot.org/uniprot/A0A072TMB0_MEDTR A0A072TMB0_MEDTR] | |||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
Inorganic pyrophosphatases (PPases, EC 3.6.1.1), which hydrolyze inorganic pyrophosphate to phosphate in the presence of divalent metal cations, play a key role in maintaining phosphorus homeostasis in cells. DNA coding inorganic pyrophosphatases from Arabidopsis thaliana ( At PPA1) and Medicago truncatula ( Mt PPA1) were cloned into a bacterial expression vector and the proteins were produced in Escherichia coli cells and crystallized. In terms of their subunit fold, At PPA1 and Mt PPA1 are reminiscent of other members of Family I soluble pyrophosphatases from bacteria and yeast. Like their bacterial orthologs, both plant PPases form hexamers, as confirmed in solution by multi-angle light scattering and size-exclusion chromatography. This is in contrast to the fungal counterparts, which are dimeric. Unexpectedly, the crystallized At PPA1 and Mt PPA1 proteins lack ~30 amino acid residues at their N-termini, as independently confirmed by chemical sequencing. In vitro , self-cleavage of the recombinant proteins is observed after prolonged storage or during crystallization. The cleaved fragment corresponds to a putative signal peptide of mitochondrial targeting, with a predicted cleavage site at Val31-Ala32. Site-directed mutagenesis shows that mutations of the key active site Asp residues dramatically reduce the cleavage rate, which suggests a moonlighting proteolytic activity. Moreover, the discovery of autoproteolytic (rather than mitochondrion-mediated) cleavage of a mitochondrial-targeting peptide would change our perception of this signaling process. | |||
Crystal structures of plant inorganic pyrophosphatase, an enzyme with a moonlighting autoproteolytic activity.,Grzechowiak M, Ruszkowski M, Sliwiak J, Szpotkowski K, Sikorski M, Jaskolski M Biochem J. 2019 Aug 1. pii: BCJ20190427. doi: 10.1042/BCJ20190427. PMID:31371393<ref>PMID:31371393</ref> | |||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |||
[[Category: | </div> | ||
[[Category: | <div class="pdbe-citations 6mt2" style="background-color:#fffaf0;"></div> | ||
[[Category: Grzechowiak | |||
[[Category: | ==See Also== | ||
*[[Inorganic pyrophosphatase 3D structures|Inorganic pyrophosphatase 3D structures]] | |||
== References == | |||
<references/> | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Large Structures]] | |||
[[Category: Medicago truncatula]] | |||
[[Category: Dauter Z]] | |||
[[Category: Grzechowiak M]] | |||
[[Category: Ruszkowski M]] | |||
Latest revision as of 09:38, 11 October 2023
Crystal structure of Inorganic Pyrophosphatase from Medicago truncatula (I23 crystal form)Crystal structure of Inorganic Pyrophosphatase from Medicago truncatula (I23 crystal form)
Structural highlights
FunctionPublication Abstract from PubMedInorganic pyrophosphatases (PPases, EC 3.6.1.1), which hydrolyze inorganic pyrophosphate to phosphate in the presence of divalent metal cations, play a key role in maintaining phosphorus homeostasis in cells. DNA coding inorganic pyrophosphatases from Arabidopsis thaliana ( At PPA1) and Medicago truncatula ( Mt PPA1) were cloned into a bacterial expression vector and the proteins were produced in Escherichia coli cells and crystallized. In terms of their subunit fold, At PPA1 and Mt PPA1 are reminiscent of other members of Family I soluble pyrophosphatases from bacteria and yeast. Like their bacterial orthologs, both plant PPases form hexamers, as confirmed in solution by multi-angle light scattering and size-exclusion chromatography. This is in contrast to the fungal counterparts, which are dimeric. Unexpectedly, the crystallized At PPA1 and Mt PPA1 proteins lack ~30 amino acid residues at their N-termini, as independently confirmed by chemical sequencing. In vitro , self-cleavage of the recombinant proteins is observed after prolonged storage or during crystallization. The cleaved fragment corresponds to a putative signal peptide of mitochondrial targeting, with a predicted cleavage site at Val31-Ala32. Site-directed mutagenesis shows that mutations of the key active site Asp residues dramatically reduce the cleavage rate, which suggests a moonlighting proteolytic activity. Moreover, the discovery of autoproteolytic (rather than mitochondrion-mediated) cleavage of a mitochondrial-targeting peptide would change our perception of this signaling process. Crystal structures of plant inorganic pyrophosphatase, an enzyme with a moonlighting autoproteolytic activity.,Grzechowiak M, Ruszkowski M, Sliwiak J, Szpotkowski K, Sikorski M, Jaskolski M Biochem J. 2019 Aug 1. pii: BCJ20190427. doi: 10.1042/BCJ20190427. PMID:31371393[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||